Company profile: RoslinCT
1.1 - Company Overview
Company description
- Provider of cell therapy CDMO services, including cGMP clinical and commercial manufacturing; process and analytical development; iPSC cell line development and manufacture; and CRISPR-edited cell therapy product development. Offers expertise across cell types, genetic modification, cell expansion, and analytical testing (multi-color flow cytometry, ELISA, qPCR).
Products and services
- CGMP Manufacturing: Produces cGMP-compliant clinical- and commercial-scale capacity for cell therapy products, delivering manufacturing for therapeutic candidates through clinical programs and commercial supply
- IPSC Cell Line Development and Manufacture: Specializes in iPSC-based line development and manufacture for cell therapies, fabricating induced pluripotent stem cell lines for therapeutic applications
- Process and Analytical Development: Engineers cell therapy–specific process and analytical development, leveraging multi-color flow cytometry, ELISA, and qPCR for product testing of cell therapy products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to RoslinCT
Agritope
HQ: United States
Website
- Description: Provider of new fruit and vegetable plant varieties for the fresh produce industry, utilizing patented ethylene control technology to develop fruits and vegetables resistant to the decaying effects of ethylene.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agritope company profile →
Renova Therapeutics
HQ: United States
Website
- Description: Provider of gene therapies for chronic diseases, focusing on cardiovascular and metabolic indications. Offerings include RT-100, a single-dose therapy to improve heart function in congestive heart failure; RT-200, a single intravenous therapy to normalize blood glucose in Type 2 Diabetes Mellitus; and paracrine gene therapy enabling systemic delivery of therapeutic genes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Renova Therapeutics company profile →
Spindiag
HQ: Germany
Website
- Description: Provider of an easy-to-use, compact, automated point-of-care PCR system for broad, fast, and affordable pathogen detection. The Rhonda player with Rhonda disks detects infectious agents—including SARS-CoV-2, Influenza A/B, RSV, and MRSA—with results in under one hour; the SARS-CoV-2 disk supports direct swab insertion. The Rhonda app displays results for mobile use, and test outcomes can be transferred directly into patient records.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spindiag company profile →
SolveBio
HQ: United States
Website
- Description: Provider of a Genomic Intelligence Platform and on-demand expertise that monitors, gathers, and secures genomic data to drive precision medicine, serving pharma, biotech, and diagnostic organizations with a contextual knowledge hub to connect and use external and internal genomic information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SolveBio company profile →
eGenesis
HQ: United States
Website
- Description: Provider of gene editing and genome engineering solutions to create human-compatible porcine organs and cells for transplantation. Offers HuCo organs and cells via the EGEN Platform, which addresses cross-species molecular incompatibilities and viral risks, enabling xenotransplantation to help address the global organ shortage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eGenesis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for RoslinCT
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to RoslinCT
2.2 - Growth funds investing in similar companies to RoslinCT
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for RoslinCT
4.2 - Public trading comparable groups for RoslinCT
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →